These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2974747)

  • 1. Regional differences in reappearance of D2-dopamine receptors in the rat caudate-putamen complex after irreversible inactivation.
    Loopuijt LD; Sebens JB; Korf J
    Brain Res; 1988 Jul; 456(2):263-70. PubMed ID: 2974747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
    Camus A; Javoy-Agid F; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.
    Der-Ghazarian T; Gutierrez A; Varela FA; Herbert MS; Amodeo LR; Charntikov S; Crawford CA; McDougall SA
    Neuroscience; 2012 Dec; 226():427-40. PubMed ID: 23000622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of dopamine D-2 receptors in the rat striatal complex and its comparison with acetylcholinesterase.
    Loopuijt LD
    Brain Res Bull; 1989 May; 22(5):805-17. PubMed ID: 2527585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.
    McDougall SA; Valentine JM; Gonzalez AE; Humphrey DE; Widarma CB; Crawford CA
    Psychopharmacology (Berl); 2014 Apr; 231(8):1637-47. PubMed ID: 24287603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
    Ekman A; Eriksson E
    Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
    Dubois A; Scatton B
    Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: localization to intrinsic neurons and not to neocortical afferents.
    Joyce JN; Marshall JF
    Neuroscience; 1987 Mar; 20(3):773-95. PubMed ID: 2955247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation.
    Joyce JN; Loeschen SK; Marshall JF
    Brain Res; 1985 Jul; 338(2):209-18. PubMed ID: 3161583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences.
    Falardeau P; Di Paolo T
    Neurosci Lett; 1987 Feb; 74(1):43-8. PubMed ID: 2951620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS; George T; Baldessarini RJ
    Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade.
    Neve KA; Loeschen S; Marshall JF
    Brain Res; 1985 Mar; 329(1-2):225-31. PubMed ID: 3156659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.